Yukiko Aikawa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Enhancer of zeste 2 polycomb repressive complex 2 subunit overexpression suppresses apoptosis in canine T-cell lymphoma: an in vitro functional analysis.

Enhancer of zeste 2 polycomb repressive complex 2 subunit overexpression suppresses apoptosis in canine T-cell lymphoma: an in vitro functional analysis.

Journal: Frontiers in veterinary science
Published: March 05, 2026

MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma.

MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma.

Journal: Cancer letters
Published: August 21, 2025

CTCF Is Essential for the Development and Maintenance of CALM-AF10-Induced Leukemia.

CTCF Is Essential for the Development and Maintenance of CALM-AF10-Induced Leukemia.

Journal: Cancer science
Published: December 27, 2024

EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung Cancer.

EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung Cancer.

Journal: Cancer immunology research
Published: June 06, 2024

Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia.

Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia.

Journal: Leukemia
Published: January 25, 2024

Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1.

Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1.

Journal: International journal of hematology
Published: June 14, 2022

MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.

MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.

Journal: Blood advances
Published: September 28, 2020

Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.

Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.

Journal: Leukemia
Published: August 13, 2020

Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Journal: Oncogene
Published: December 20, 2018

Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.

Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.

Journal: Blood
Published: May 25, 2017

Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.

Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.

Journal: Cancer science
Published: August 08, 2014

IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.

IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.

Journal: Cancer research
Published: July 30, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026